$GSK Company News U.K. stocks pare losses after inflation

New Post Public Reply Private Reply Replies (0) Message Board

Nov 12, 2013 at 11:25 PM

$GSK Company News

U.K. stocks pare losses after inflation data 12:00 p.m. Today - Sara Sjolin
FTSE 100 climbs for third day, Aggreko rallies 1:31 p.m. Oct. 28, 2013 - Sara Sjolin
Glaxo, miners pull FTSE 100 from five-month high 12:26 p.m. Oct. 23, 2013 - Sara Sjolin
Banks hit Europe after ECB stress-test news 12:04 p.m. Oct. 23, 2013 - Sara Sjolin
Drug-maker earnings come in ahead of views, but stocks aren't rewarded 11:45 a.m. Oct. 23, 2013 - blogs.marketwatch.com
GSK sales to China down 61% on bribery probe 7:42 a.m. Oct. 23, 2013 - MarketWatch.com
5 of the biggest corporate fines ever 2:40 p.m. Oct. 21, 2013 - Jonnelle Marte
GSK sells thrombosis brands to Aspen for $1.13 bln 7:46 a.m. Sept. 30, 2013 - MarketWatch.com
J.P. Morgan launches fund with Gates Foundation 10:17 a.m. Sept. 23, 2013 - MarketWatch.com
BlackBerry plunges as it slashes jobs, forecasts 4:57 p.m. Sept. 20, 2013 - Saumya Vaishampayan
Two upgrades, two downgrades from Barclays on Euro drug makers 12:46 p.m. Sept. 16, 2013 - blogs.marketwatch.com
U.K.’s FTSE 100 rises to six-week high 12:40 p.m. Sept. 16, 2013 - Sara Sjolin
FDA votes for GSK, Thereavance lung-disease drug 2:50 a.m. Sept. 11, 2013 - MarketWatch.com
Mylan shares jump after FDA lays out guidelines for asthma generic 2:47 p.m. Sept. 10, 2013 - blogs.marketwatch.com
Miners, banks lead FTSE higher after China data 12:16 p.m. Sept. 10, 2013 - Sara Sjolin
European stocks rally after upbeat China data 12:10 p.m. Sept. 10, 2013 - Sara Sjolin
Asian shares rise on upbeat Chinese data 4:55 a.m. Sept. 10, 2013 - Daniel Inman
BG leads FTSE 100 lower after forecast downgrade 12:08 p.m. Sept. 9, 2013 - Sara Sjolin
GSK sells Lucozade, Ribena to Suntory for $2.1 bln 4:09 a.m. Sept. 9, 2013 - MarketWatch.com
U.S. expands Glaxo probe to include China 11:21 a.m. Sept. 7, 2013 - MarketWatch.com

GlaxoSmithKline Drug Falls Short, Sarepta Shares Collapse, and 3 More Hot Stocks 11:56 a.m. Today - Wall St. Cheat Sheet
Sarepta Serious Setback: FDA Says No Early Approval Filing for Eteplirsen (Updated) 10:25 a.m. Today - TheStreet.com
GSK Pivotal Phase III Study of Darapladib in Chronic Coronary Heart Disease Gid Not Meet Primary Endpoint 5:11 a.m. Today - benzinga.com
Pre-Market Activity Shows Heavy Volume And Movement For GlaxoSmithKline (GSK) 8:56 a.m. Nov. 11, 2013 - TheStreet.com
China Biotech In Review: Cytori Signs $531 Million Deal With New Australian Company 3:22 a.m. Nov. 10, 2013 - Seeking Alpha
4 Healthcare Sector Dogs Hype 13% To 17% October Upsides; 4% To 7.5% Downsides 7:02 p.m. Nov. 8, 2013 - Seeking Alpha
Make A Suave Move, Buy Novartis 2:37 p.m. Nov. 8, 2013 - Seeking Alpha
GlaxoSmithKline: Offering Stable And Juicy Dividend Yield 1:42 p.m. Nov. 8, 2013 - Seeking Alpha
Dynavax Reports In-Line Loss, Beats Rev - Analyst Blog 12:00 p.m. Nov. 8, 2013 - Zacks.com
Merck Looks Like a Relative Bargain 6:00 a.m. Nov. 8, 2013 - TheStreet.com
Agenus Valuation After Positive HerpV Vaccine Results 2:46 p.m. Nov. 7, 2013 - Seeking Alpha
Will GlaxoSmithKline Continue to Trend Higher? 8:29 a.m. Nov. 6, 2013 - Wall St. Cheat Sheet
These 48 Blue Chips Are On the Move 4:40 a.m. Nov. 6, 2013 - InvestorPlace.com
Ligand Pharmaceuticals On Pace For Annual Profit 4:25 p.m. Nov. 5, 2013 - Investors Business Daily
Will GlaxoSmithKline Get Away in China? 5:10 p.m. Nov. 4, 2013 - Wall St. Cheat Sheet
Update on Glaxo's Respiratory Portfolio - Analyst Blog 4:30 p.m. Nov. 4, 2013 - Zacks.com
Johnson & Johnson Agrees to $2B DOJ Settlement 11:08 a.m. Nov. 4, 2013 - FOXBusiness
GlaxoSmithKline Dodges China Bullet, Dish-Disney Deal Remains Elusive, and 2 More Hot Stocks 11:07 a.m. Nov. 4, 2013 - Wall St. Cheat Sheet
Why I'm More Confident in Sarepta Than Ever Before 10:06 a.m. Nov. 4, 2013 - TheStreet.com
Pfizer's Not Losing Its Kingpin Status 6:00 a.m. Nov. 4, 2013 - TheStreet.com

WPP'S GO Team Awarded Tums and Eno Global Account by GlaxoSmithKline 3:26 p.m. Nov. 11, 2013 - PR Newswire
Morning Research: GlaxoSmithKline PLC, Keryx Biopharma Inc., AstraZeneca PLC, and Raptor Pharma Corp. 8:00 a.m. Nov. 11, 2013 - PR Newswire
Upcoming Presentations, New Studies, and Stock Price Movements - Research Report on WellPoint, GSK, Forest Laboratories, Intuitive Surgical, and Cubist Pharmaceuticals 8:00 a.m. Nov. 11, 2013 - PR Newswire
Cannabis Biotech Files Patent Application for Metered-Dose Dispensing Device 8:30 a.m. Nov. 4, 2013 - BusinessWire
Media Advisory: GSK Recalls Two Lots of Migraine Medication: IMITREX Injection 5:52 p.m. Nov. 1, 2013 - Marketwire
Dividend, Quarterly Report, Recognition, Study Results, and New Drug Application - Research Report on Pfizer, Lilly, Regeneron, Vertex, and GSK 9:00 a.m. Nov. 1, 2013 - PR Newswire
BREO® ELLIPTA(TM) now available in the U.S. for the treatment of COPD 10:09 a.m. Oct. 30, 2013 - PR Newswire
Critical Alerts For GlaxoSmithKline, Deutsche Bank, Cummins, Canadian Solar, and Isis Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Oct. 30, 2013 - PR Newswire
BREO(R) ELLIPTA(TM) Now Available in the U.S. for the Treatment of COPD 9:01 a.m. Oct. 30, 2013 - Marketwire
Cannabis Biotech in Talks With Research Chemist to Explore Transmucosal Delivery 8:30 a.m. Oct. 29, 2013 - BusinessWire
FDA Approval, FDA Application, Positive Safety Results, and Presentations - Research Report on Cubist, GSK, Rockwell Medical, Arrowhead, and Horizon Pharma 8:00 a.m. Oct. 24, 2013 - PR Newswire
Lamotrigine is One of the Most Commonly Prescribed Drugs Among Newly Diagnosed Bipolar Disorder Patients in the United States 8:00 a.m. Oct. 23, 2013 - PR Newswire
GlaxoSmithKline CFO Interviewed on Q3 results 7:56 a.m. Oct. 23, 2013 - PR Newswire
ViiV Healthcare announces US regulatory submission for a single-tablet regimen combining dolutegravir with abacavir and lamivudine for people living with HIV 12:53 p.m. Oct. 22, 2013 - PR Newswire
At One Month Post-Launch, Nearly a Quarter of Surveyed U.S. Oncologists Have Prescribed Tafinlar for Malignant Melanoma, Compared to 15 Percent Who Used Mekinist 11:43 a.m. Oct. 22, 2013 - PR Newswire
Maxalt/Maxalt MLT is the Most Commonly Prescribed Branded Triptan Used by Newly Diagnosed Migraine Patients in the United States 10:00 a.m. Oct. 22, 2013 - PR Newswire
Cannabis Biotech Launches Development of Transmucosal Delivery System 8:30 a.m. Oct. 21, 2013 - BusinessWire
Financial Results, Quarterly Earnings Schedules, Marketing Authorizations, Completed Acquisitions, and New Drug Applications - Research Report on Johnson & Johnson, AbbVie, GSK, AstraZeneca, and Keryx 8:00 a.m. Oct. 18, 2013 - PR Newswire
Technical Study: AstraZeneca PLC, GlaxoSmithKline PLC, Keryx Biopharma Inc., and Raptor Pharma Corp. 12:51 p.m. Oct. 17, 2013 - PR Newswire
Medivir: Janssen Has Acquired an NS5a Replication Complex Inhibitor That Will Be Evaluated with Simeprevir in Future Clinical Development 9:06 a.m. Oct. 8, 2013 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASUR's October Traffic Sees Mixed Results Across Regions

A Patchwork of Gains and Losses Take a look at Grupo Aeroportuario del Sureste, S.A.B. de C.V. (NYSE: ASR), and you’ll see a mixed bag when it comes to October 2026’s passenger traffic. While some regions like Puerto Rico and Colombia took a step forward, others like Mexico and Costa Rica tripped up, resulting in an overall decline of 0.9% compared to last October....

MCAP's Q3 Earnings: Sizing Up the Tech Game

Quarterly Results: The Numbers to Watch Alright, here's the scoop from MCAP Inc.: they just tossed their hat in the quarterly earnings ring, flexing a third quarter EPS of $0.15 a share. Not exactly champagne-popping numbers, but hey, let's not throw out the party favors just yet. Revenues rolled in at a neat $26.7 million, with EBITDA tagging along at $5.2 million. So,...

Pure Hockey Expands in SoCal: New Store in El Segundo

Another Marker on Pure Hockey's Expansion Path Look, you might not have pegged California as a hockey hotbed a few decades back, but here we are, with Pure Hockey planting yet another flag in El Segundo. It marks their fifth outpost in the Golden State, enhancing access for players in the South Bay area. Makes you think about how far the game’s roots have spread across...

Habitat for Humanity AZ's Unique Gala: An Overview

Mark Your Calendars: A Night to Celebrate Listen up, Central Arizona, because I'm giving you the lowdown on Habitat for Humanity Central Arizona's big night out. "Blueprints & Blue Jeans" - it's the gala that's ditching the formalities for some good old-fashioned community fun, but with a seriously important mission at its heart. Mark your calendars for Friday, March 5,...

WIC 2026: Global Connectivity and Cyber Futures

Connectivity Takes Center Stage in Wuzhen When you throw 1,800 movers and shakers into a room focused on the future of the internet, sparks are gonna fly. That's exactly what's going down at the 2026 World Internet Conference in Wuzhen, China. Brass tacks: this ain't just another snooze-fest. The theme this year screams significance—'Open Source and Openness, Joined...

Encore Boston Harbor Workers Triumph After 62-Day Strike

Labor Standoff at Encore Boston Harbor Ends After a stormy 62 days on the picket lines, around 1,300 workers at Encore Boston Harbor finally find themselves back at their posts, carrying with them the spoils of hard-fought victory. This isn't just a paper contract; it's a banner for worker solidarity. These aren't your run-of-the-mill stock flips, folks; this fight was...

Yiren Digital Faces Class Action by Investors

Yiren's Stormy Seas: A Tale of Instability If you're holding a stake in Yiren Digital Ltd. (NYSE: YRD), you're likely feeling the heat right now. It's been a ride down a bumpy road with stock prices taking a nosedive—plummeting 44.05% on news that's got investors seeing red. The Nuts and Bolts of the Class Action What's the big fuss, you ask? Well, the lawsuit is no...

Esperto's Space Health Tech Eyes Terrestrial Gains

The cosmos isn't just a playground for astronauts. It's a proving ground for the next wave of medical innovation, courtesy of Esperto Medical. They're trotting into uncharted territory with the Translational Research Institute for Space Health (TRISH) grant in hand, determined to transform healthcare both in space and on our own turf. Groundbreaking Tech for Extreme...

Teneo Expands Financial Advisory in Canada, Eyes Talent

Turning the Maple Leaf Over: Teneo's Move Alright, here's the scoop: Teneo is muscling its way north, into Canada, to flex its Financial Advisory chops. With a lineup of 60 professionals already setting the pace across Toronto, Montreal, and Calgary, this move isn’t just smoke—it’s a full-fledged expansion. They're under the hood, tinkering away to beef up...

XCMG Spurs 'AI + Construction' Innovation at Event

XCMG's Big Push for Smarter Machinery China's construction machinery titan XCMG just wrapped up a fireworks show of innovation in Xuzhou, highlighting some sharp AI-driven machinery projects. Their recent 'AI + Construction Machinery' competition pulled in minds from over 20 countries, all aiming to rethink how these hulking machines operate. AI and Machinery: A Match...